参考文献/References:
[1]胡大一.心血管疾病和精神心理障碍的综合管理——“双心医学”模式的探索[J].中国临床医生,2006,34(5):2-3.
[2]STRIK J J,DENOLLET J,LOUSBERG R,et al.Comparing symptoms of depression and anxiety as predictors of cardiac events and increased health care consumption after myocardial infarction[J].J Am Coll Cardiol,2003,42(10):1801-1807.
[3]LESPERANCE F,FRASURE-SMITH N,TALAJIC M,et al.Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction[J].Circulation,2002,105(9):1049-1053.
[4]朱继芳,李远琼,陈朝蓉,等.冠心病患者焦虑抑郁现状及影响因素调查[J].激光杂志,2014,35(9):127-129.
[5]张六燕,李莹鸿,何鑫,等.疏肝护心方对冠心病伴焦虑抑郁患者心理状态和炎症因子的影响[J].广州中医药大学学报,2023,40(1):63-68.
[6]KUHLMANN S L,AROLT V,HAVERKAMP W,et al.Prevalence 12-month prognosis and clinical management need of depression in coronary heart disease patients: A prospective cohort study[J].Psychother Psychosom,2019,88(5):300-311.
[7]PIZZI C,MANZOLI L,MANCINI S,et al.Analysis of potential predictors of depression among coronary heart disease risk factors including heart rate variability markers of inflammation and endothelial function[J].Eur Heart J,2008,29(9):1110-1117.
[8]LECHNER K,VON SCHACKY C,MCKENZIE A L,et al.Lifestyle factors and high-risk atherosclerosis: Pathways and mechanisms beyond traditional risk factors[J].Eur J Prev Cardiol,2020,27(4):394-406.
[9]崔青扬,丁建东,李浩,等.5-羟色胺转运体基因多态性与冠心病合并抑郁相关性的Meta分析[J].东南大学学报:(医学版),2015,34(5):792-796.
[10]董春彦,周美娟,张铁军,等.益气化浊利水方治疗气虚血瘀型胸痹心痛疗效观察[J].中医药学报,2022,50(9):76-79.
[11]于瑞,牛琳琳,陈彦,等.中医药在双心医学领域的干预探讨[J].世界中西医结合杂志,2015,10(12):1748-1749.
[12]晁田田,张大武,孙敬辉,等.冠心病合并焦虑或抑郁状态中医证候及证素分布特点的现代文献研究[J].世界科学技术-中医药现代化,2020,22(5):1405-1411.
[13]姚睿祺,张瑾,杨德爽,等.桂枝茯苓丸治疗心系疾病的理论及应用探析[J].中医杂志,2022,63(7):688-690.
[14]张文秀,牟鲁华.中医治疗双心疾病研究进展[J].实用中医药杂志,2024,40(5):1030-1034.
[15]刘庆阳,王振涛.柴胡加龙骨牡蛎汤治疗双心疾病的研究进展[J].中西医结合心脑血管病杂志,2024,22(10):1802-1809.
[16]高佳慧,吴希泽,张家瑞,等.温胆汤方治疗双心疾病的研究进展[J].中医临床研究,2024,16(30):86-91.
[17]万兆新,苏同生.从“形神一体”理论谈耳鸣的治疗[J].陕西中医,2012,33(11):1569.
[18]杜渐,孔军辉,杨秋莉.情志相胜干预抑郁症机理的理论探析[J].中国中医基础医学杂志,2020,26(6):739-741.
[19]卢欣迟,胡传宇,曹亚丽,等.基于“五志过极”探讨缺血性中风与情志的关系[J].中国中医基础医学杂志,2022,28(11):1788-1790.
[20]徐宁阳,周春桐,马原,等.中医辨证治疗双心疾病的新探索[J].中华中医药杂志,2023,38(3):948-952.
[21]刘鑫,于嘉祥,曲超,等.基于双心医学理论和分子对接技术探讨柴胡-黄芩药对治疗冠心病的作用机制[J].辽宁中医药大学学报,2023,25(2):184-191.
[22]王超,王昀,赵海滨.从中医“双心学说”探析冠心病合并焦虑的论治思路[J].环球中医药,2016,9(12):1476-1478.
[23]李董男.从金元四大家理论探讨“扶正祛邪”辨治疫病思路[J].湖北民族大学学报(医学版),2020,37(3):69-72.
[24]董洪飞,李茜,赵凤英,等.从“凡郁病必先气病”论郁证[J].湖北中医杂志,2023,45(4):48-51.
[25]潘姿钢,陈品良,吴辉,等.从免疫炎症调控探讨益气活血疏肝法治疗双心疾病的作用机制[J].中医杂志,2023,64(12):1211-1217.
[26]齐鑫,赵海滨.基于“双心理论”探讨稳定型心绞痛合并抑郁病人中医证候分布及危险因素[J].中西医结合心脑血管病杂志,2022,20(21):3955-3959.
[27]苏翔.冠心病伴焦虑抑郁患者中医证型与证素特征的调查研究[D].乌鲁木齐:新疆医科大学,2019.
[28]姚怡,王庆其.论《黄帝内经》“心主血脉”理论对冠心病诊治的启发[J].中华中医药杂志,2017,32(6):2397-2401.
相似文献/References:
[1]朱 薇.通脉调脂方治疗冠心病稳定性心绞痛疗效及对患者血流变、VCAM1〖JZ〗及ICAM1影响的研究*[J].陕西中医,2019,(3):290.
ZHU Wei..Effect of Tongmai Tiaozhi recipe on the efficacy, Hemorheology, VCAM1 and ICAM1 〖JZ〗in patients with stable angina pectoris of coronary heart disease[J].,2019,(11):290.
[2]时晓华.丹参多酚酸盐注射液辅助介入治疗冠心病 及对患者心、肾功能和心肌损伤的影响*[J].陕西中医,2019,(5):568.
SHI Xiaohua..Effects of salvianolate injection on cardiac function, renal function, myocardial injury in percutaneous coronary intervention postoperative patients with coronary heart disease[J].,2019,(11):568.
[3]刘 红,张玲燕,杨 玲.血府逐瘀汤治疗冠心病介入术后心绞痛临床研究[J].陕西中医,2019,(5):594.
LIU Hong,ZHANG Lingyan,YANG Ling..Clinical observation of Xuefu Zhuyu decoction in the treatment of angina pectoris after PCI for coronary heart disease[J].,2019,(11):594.
[4]吕永飞,陈爱莲.益心康泰胶囊治疗冠心病经皮冠状动脉介入术术后疗效及对患者血流变、血管内皮功能的影响*[J].陕西中医,2019,(6):714.
LV Yongfei,CHEN Ailian..Effect of Yixin Kangtai capsule on the curative effect hemorheology and vascular endothelial function after coronary artery disease PCI[J].,2019,(11):714.
[5]贺建涛,胡宇才,刘 磊.活血通络散治疗冠心病PCI术后心绞痛疗效研究*[J].陕西中医,2019,(7):854.
HE Jiantao,HU Yucai,LIU Lei..Efficacy observation of Huoxue Tongluo powder in the treatment of angina pectoris after coronary heart disease PCI[J].,2019,(11):854.
[6]解洪涛,张 顺△,曾广伟.当归补血方联合西药治疗冠脉搭桥术后疗效及对患者血瘀证证候评分和凝血功能的影响*[J].陕西中医,2019,(10):1341.
XIE Hongtao,ZHANG Shun,ZENG Guangwei..Effects of Danggui Buxue prescription combined with western medicine on blood stasis and coagulation function after coronary artery bypass grafting[J].,2019,(11):1341.
[7]索晓菲,王亚红△,王居新,等.软坚通脉汤治疗冠心病PCI术后Ⅱ期心脏康复疗效〖JZ〗及对患者生活质量的影响*[J].陕西中医,2020,(1):29.
[8]尹 毅,李小兰△.益气活血汤联合尼可地尔治疗稳定性心绞痛疗效及对患者T淋巴细胞亚群的影响[J].陕西中医,2020,(7):888.[doi:DOI:10.3969/j.issn.10007369.2020.07.014]
[9]季学清,刘 萍△,陈宝瑾,等.冠心康方加减联合西药治疗冠心病合并2型糖尿病气虚痰瘀证疗效研究*[J].陕西中医,2020,(9):1208.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.008]
JI Xueqing,LIU Ping,CHEN Baojin,et al.Efficacy of Guanxinkang preparation combined with western medicine in the treatment of coronary heart disease and type 2 diabetes mellitus with syndrome of Qixu Tanyu[J].,2020,(11):1208.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.008]
[10]董其浩,邓 兵.益脉强心汤对冠心病合并心衰患者心室重构及血清血小板活化因子、转化生长因子-β1的影响[J].陕西中医,2021,(7):883.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.018]